University of East Anglia Featured PhD Programmes
University of Southampton Featured PhD Programmes
University College London Featured PhD Programmes
10 miles

University of Leeds, Faculty of Medicine and Health Cancer / Oncology PhD Projects, Programs & Scholarships

We have 8 University of Leeds, Faculty of Medicine and Health Cancer / Oncology PhD Projects, Programs & Scholarships

  • Cancer / Oncology×
  • University of Leeds
  • Faculty of Medicine and Health×
  • clear all
Order by 
Showing 1 to 8 of 8
  Enhancing Oncolytic Virus-induced Immunotherapy using Eicosapentaenoic Acid (EPA)
  Dr F Errington-Mais, Dr MA Volpato
Applications accepted all year round

Funding Type

PhD Type

Breast cancer is the most commonly diagnosed cancer in women with triple-negative breast cancer (TNBC) having the worst prognosis, highest death rate and lowest overall survival.
  Epigenetic therapy using ultrasound-mediated microbubble drug delivery for cancer treatment
  Dr E Valleley, Dr L Coletta
Applications accepted all year round

Funding Type

PhD Type

The project is an interdisciplinary, pre-clinical study that aims to investigate the response of human tumour cells to treatment with epigenetic inhibitors (such as DNA methyltransferase inhibitors), as a potential combination therapy for colorectal cancer (CRC).
  Gastroesophageal reflux in respiratory disease: pathogenic role and improved management
  Prof L Houghton
Applications accepted all year round

Funding Type

PhD Type

Gastroesophageal reflux (GER) is associated with many lung diseases, including but not limited to idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease (ILD), chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), non-CF bronchiectasis, asthma and idiopathic chronic cough.
  Identification and functional characterisation of BRIT1/MCPH1 synthetic lethal genes to treat breast and ovarian cancer
  Dr S Bell, Prof C A Johnson
Applications accepted all year round

Funding Type

PhD Type

Women who have undergone surgery for breast and ovarian cancer often have additional chemotherapy to kill residual cancer cells and prevent recurrence.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
  Oncogenic mechanisms causing malignant transformation of lymphoid cells
  Prof U Klein
Applications accepted all year round

Funding Type

PhD Type

Cancers of B cells and plasma cells, lymphomas and multiple myeloma, can be very aggressive, and often the cancer rapidly reoccurs after standard therapy.
  Patient centred models for surveillance and support for breast cancer survivors
  Prof G Velikova, Dr S Gelcich, Dr K Absolom
Application Deadline: 15 April 2020

Funding Type

PhD Type

Improvements in cancer treatment have led to an increasing number of patients being cured or in remission, who are still followed up to detect recurrence, manage persistent symptoms and late treatment effects.
  The functional characterization of the tumour suppressor gene CSMD1 in breast cancer
  Dr S Bell
Applications accepted all year round

Funding Type

PhD Type

CUB and Sushi multiple domains protein 1 (CSMD1) maps to 8p23, a region deleted in many cancers including breast cancer. Our previous work has established that CSMD1 is an independent prognostic marker in ductal breast cancer, with reduced expression associated with high tumour grade and poor survival1.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2020
All rights reserved.